chr3-119923394-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2
The NM_001146156.2(GSK3B):c.456G>A(p.Thr152=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000844 in 1,573,904 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0040 ( 2 hom., cov: 32)
Exomes 𝑓: 0.00050 ( 6 hom. )
Consequence
GSK3B
NM_001146156.2 synonymous
NM_001146156.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.669
Genes affected
GSK3B (HGNC:4617): (glycogen synthase kinase 3 beta) The protein encoded by this gene is a serine-threonine kinase belonging to the glycogen synthase kinase subfamily. It is a negative regulator of glucose homeostasis and is involved in energy metabolism, inflammation, ER-stress, mitochondrial dysfunction, and apoptotic pathways. Defects in this gene have been associated with Parkinson disease and Alzheimer disease. [provided by RefSeq, Aug 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.28).
BP6
Variant 3-119923394-C-T is Benign according to our data. Variant chr3-119923394-C-T is described in ClinVar as [Benign]. Clinvar id is 721176.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.669 with no splicing effect.
BS2
High AC in GnomAd4 at 615 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GSK3B | NM_001146156.2 | c.456G>A | p.Thr152= | synonymous_variant | 4/11 | ENST00000264235.13 | |
GSK3B | NM_002093.4 | c.456G>A | p.Thr152= | synonymous_variant | 4/12 | ||
GSK3B | NM_001354596.2 | c.456G>A | p.Thr152= | synonymous_variant | 4/10 | ||
GSK3B | XM_006713610.4 | c.456G>A | p.Thr152= | synonymous_variant | 4/11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GSK3B | ENST00000264235.13 | c.456G>A | p.Thr152= | synonymous_variant | 4/11 | 1 | NM_001146156.2 | A1 |
Frequencies
GnomAD3 genomes AF: 0.00401 AC: 610AN: 152014Hom.: 2 Cov.: 32
GnomAD3 genomes
AF:
AC:
610
AN:
152014
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00120 AC: 294AN: 245640Hom.: 2 AF XY: 0.000897 AC XY: 119AN XY: 132646
GnomAD3 exomes
AF:
AC:
294
AN:
245640
Hom.:
AF XY:
AC XY:
119
AN XY:
132646
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000501 AC: 713AN: 1421772Hom.: 6 Cov.: 25 AF XY: 0.000441 AC XY: 313AN XY: 709308
GnomAD4 exome
AF:
AC:
713
AN:
1421772
Hom.:
Cov.:
25
AF XY:
AC XY:
313
AN XY:
709308
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00404 AC: 615AN: 152132Hom.: 2 Cov.: 32 AF XY: 0.00385 AC XY: 286AN XY: 74376
GnomAD4 genome
AF:
AC:
615
AN:
152132
Hom.:
Cov.:
32
AF XY:
AC XY:
286
AN XY:
74376
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 18, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at